Author

Arkajyoti Sarkar

Vrije Universiteit BrusselORCID 0009-0005-9765-280XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Anfien HuyghebaertiD· 1 shared Charlotte JanssensiD· 1 shared Claudia SpitsiD· 1 shared Diana Al DelbanyiD· 1 shared Leo A. van GrunsveniD· 1 shared Mai Chi DuongiD· 1 shared Nuša KriveciD· 1 shared Stefaan VerhulstiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperDevelopmental Biology

Anfien HuyghebaertORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Developmental BiologybioRxivPreprintMar 29, 2026

Increases in BCL2L1 and ID1 dosage synergistically drive fate bias and competitive advantage in human pluripotent stem cells

Yingnan Lei, Nuša Krivec, Arkajyoti Sarkar…·Claudia Spits

This study shows that increased BCL2L1 and ID1 gene dosage in human pluripotent stem cells drives competitive advantage and fate bias toward non-neural ectodermal and extraembryonic fates during differentiation.

1 citation

humanscRNA-seq

𝕏 PostBluesky